Clinical trials: BPH/LUTS/Sexual Functions
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a common condition among aging men that causes lower urinary tract symptoms (LUTS) and may negatively affect sexual function.
- Conditions
- Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Erectile Dysfunction
- Trial name
- DTT-BPH (NCT07715448)
- Testing
- Tamsulosin, Tadalafil, 5-Alpha Reductase Inhibitor
- Where
- Egypt
- Volunteers
- 240 people
- Sponsor
- Beni-Suef University
BPH/LUTS/Sexual Functions
Standard HoLEP vs Virtual Basket HoLEP for Treatment of BPH
We aimed to assess impart of VB-HoLEP in management of BPH
- Trial name
- VB-HOLEP (NCT07816484)
- Testing
- standard Holmium laser enucleation of the prostate, Virtual basket Holmium laser enucleation of the prostate
- Where
- Egypt
- Volunteers
- 133 people
- Sponsor
- Mansoura University
BPH/LUTS/Sexual Functions
Long Term Evaluation of Ejaculatory Hood Preserving GreenLight Laser Photoselective Vaporization of the Prostate
long term evaluation of ejaculation preserving laser prostatectomy for BPH patients
- Trial name
- EJHP-GLPVP (NCT07819032)
- Where
- Egypt
- Volunteers
- 46 people
- Sponsor
- Mansoura University
BPH/LUTS/Sexual Functions
Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy
To collect under daily practice conditions, clinical data on the changes of sexual function when a new formulation of alfuzosin(Xatral XL® )is administered once daily in patients with lower urinary tract symptoms(LUTS) suggestive…
- Trial name
- NCT00542165
- Testing
- Alfuzosin
- Where
- South Korea
- Volunteers
- 166 people
- Sponsor
- Sanofi